[1]
2023. Roundtable discussion: Navigating challenging treatment decisions in relapsed and refractory multiple myeloma (RRMM). Canadian Hematology Today. 2, s07 (Jul. 2023), 2–5. DOI:https://doi.org/10.58931/cht.2023.2s0736.